Use of ISBT 128 in the Labeling of Cellular Therapy Products Pat Distler Technical Director, ICCBBA

Slides:



Advertisements
Similar presentations
Unique Device Identification (UDI) System for Medical Devices Dr Larry Kelly Therapeutic Goods Administration.
Advertisements

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDAs website for reference purposes only. It.
HIBC UDI IMPLEMENTATION FOR THE DENTAL INDUSTRY Presented to: Dental Trade Alliance March 5, 2014 Robert A. Hankin, Ph.D. HIBCC President.
Unique Device Identifier (UDI) - Overview 6/21/2014
Hematopoietic Stem Cell Transplantation Lynn Savoie September 30, 2006.
Kathy Means Produce Marketing Association Traceability: Linking the Supply Chain Copyright PMA
1 ISBT 128 Industry Standard and Implementation Process Overview.
INTRODUCTION OF FACT/JACIE COMPLIANT ISBT 128 BARCODE LABELS FOR
Draft Guidance for Industry: Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob.
Regulatory Challenges in the Cell Preparation Facility Adrian Gee Center for Cell & Gene Therapy Regulatory Challenges in the Cell Preparation Facility.
Changes in European Eye Banking over the past 15 years The authors have no financial interest in the subject matter of this poster Ilse Claerhout 1, Hanneke.
Fundamentals of Health Information – Week 5
The Impact of MAK Implementation at a Hospital Transfusion Service Laboratory S.Delanghe, K. Eckert, K.Leigh, H. Elgie, K. Hodgins, L Thomson London Laboratory.
CBER Whole Blood and Blood Component Labeling Jennifer Jones Consumer Safety Officer CBER, OBRR, DBA September 16, 2009.
Copyright © 2006 Pearson Education, Inc. publishing as Benjamin Cummings PowerPoint® Lectures Lectures by Chris Romero, Front Range Community College Whose.
Americas Technical Advisory Group ICCBBA ISBT 128 Blood Product Labeling – A Hospital Perspective Americas Technical Advisory Group ICCBBA.
ISBT 128 Blood Product Labeling for Transfusionists Americas Technical Advisory Group ICCBBA
ISBT 128 Labelling Standard for Blood Components
SMT Proprietary and Confidential
Barcoding in the supply chain
FDA Regulation of Combination Products Barbara D. Boyan, Ph.D. American Academy of Orthopaedic Surgeons Professor and Deputy Director for Research for.
Paul Ashford. Safe Blood? Ensuring the provision of safe blood is a high priority Donor selection Testing Processing Quality assurance But...
FACT-NetCord International Standards & Accreditation Foundation for the Accreditation of Cellular Therapy March 2007 Phyllis I. Warkentin, MD.
Role of Clinicians in Promoting Voluntary Blood Donation Dr. Anju Verma.
Introduction to the ISBT 128 Labelling Standard for Blood Components
HA Lions Eye Bank Galen Chow HKEH QA Forum HKE QA Forum 2012 Acknowledgements Dr Victoria Wong Ms Janice Wong Ms Jessie Ng Ms Jenny Yeung All the.
Bridging the Gap Between Biologics & Compliance. Grant Funds Provided by Continuing Nursing Education Credit Provided by.
This presentation is the property of Paradigm Information Systems It is confidential to the intended recipient for the purpose of evaluating FMS Any other.
1 ISBT-128: It’s Finally Happening! KABB Spring Meeting March 10, 2007 Debra Bowman, MT(ASCP)SBB Quality Assurance Director Kentucky Blood Center.
RAISING THE BAR Meeting CSA Guidelines And Preparing for Health Canada
Possible elements of the technical standards Pre-sessional consultations on registries Bonn, 2-3 June 2002 Andrew Howard UNFCCC secretariat
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download, adapt, and distribute this.
Current Considerations on Plasma for Further Manufacturing Obtained from Whole Blood Donors Alan E. Williams, Ph.D. Associate Director for Regulatory Affairs,
Apheresis Blood Components
REGULATIONS FOR BLOOD and BLOOD PRODUCTS JILL HOAG BS, SBB(ASCP) CQA(ASQ) AABB STAFF LEAD ASSESSOR 1.
ISBT 128 Implementation Changes to Blood Component Labels Spring 2009 Val Paulson, Hospital Liaison Specialist Prairie Region.
Leukocyte-Reduced Blood Components Lore Fields MT(ASCP)SBB Consumer Safety Officer, DBA, OBRR, CBER September 16, 2009.
Health IT Workforce Curriculum Version 1.0 Fall Networking and Health Information Exchange Unit 3b National and International Standards Developing.
Archival Workshop on Ingest, Identification, and Certification Standards Certification (Best Practices) Checklist Does the archive have a written plan.
The International Society For Cellular Therapy. Mission Statement ISCT is a global association driving the translation of scientific research to deliver.
Introduction to the ISBT 128 Labelling Standard for Blood Components.
ICT in Healthcare. Electronic prescription service GPs and nurses can send electronic prescriptions to a dispenser (pharmacy) of the patients choice.
FDA EID Workshop: Day 2 Organs, Tissues and Cells Melissa A. Greenwald, MD Blood Products Advisory Committee 26 July 2010 Gaithersburg, MD.
Update on Transfusion Safety Management Systems Blood Products Advisory Committee Meeting, March 9, 2006 Linda Weir, CSO, CBER/OBRR/DBA.
Barcode Technology in healthcare Nowadays, published reports illustrate high rates of medical error (adverse events) and the increasing costs of healthcare.
1 October, 2015 HL 7 Working Group Meeting. FDA UDI Rule – 9/24/2013 Unique device identifier (UDI) means an identifier that adequately identifies a device.
OPTN Proposal to Require Extra Vessels Disposition Reporting to the OPTN in Five Days of Transplant or Disposal Sponsored by the Operations and Safety.
Comments of International Society for Cellular Therapy (ISCT) to FDA Cellular, Tissue, & Gene Therapies Advisory Committee Elizabeth Read, MD March 30,
Sample Collection Training Guide. Sample Collection Overview It is the responsibility of the transfusing facility to collect and properly label blood.
ICE Collaboration with EU Anne Mette T. Johansen & Birthe Frimodt-Møller Denmark International Collaborative Effort on Injury Statistics May.
1 Copyright © 2009, 2006, 2003, 2000, 1997, 1994 by Saunders, an imprint of Elsevier Inc. Chapter 23 Nursing Informatics.
1 Summary of FDA Guidance for Industry Standards for Securing the Drug Supply Chain – Standardized Numerical Identification for Prescription Drug Packages.
Introduction to the NHLBI Context. Agenda  Introduction to the NMDP / CIBMTR  Forms being curated  Progress update  Description of review process.
IDMP Overview December 2015.
DEPARTMENT OF HEALTH CENTER FOR BIOLOGICS AND HUMAN SERVICESEVALUATION and RESEARCH AND HUMAN SERVICES EVALUATION and RESEARCH Update on the Somatic Cell.
Cord Blood Presentation to the AZ House Health Committee Charis Ober Save the Cord Foundation January 12, 2016.
Tissue Management Using SoftBank
ISO/IEEE Support for UDI
HIBC UDI IMPLEMENTATION FOR THE DENTAL INDUSTRY
ISBT 128 Blood Product Labeling Americas Technical Advisory Group ICCBBA © Copyright ICCBBA, Inc.
Introduction to Immunohematology
Co-Chairs: Paul Ashford, Executive Director ICCBBA
The Future of SoftBank Presented by:
2008 Group 7: Healthcare, Barcoding and Safety – Beyond Medication
Crossing the Chasm Toward RFID and Bar Code Co-existence
Operations and Safety Committee
LabCraft A complete IT system for Blood banks and transfusion service.
Cyto-Care… specialized in cell collection.
Allogeneic Stem Cell Transplantation for Aplastic Anemia
Effect of donor and recipient CMV serostatus on survival after HSCT in 2 large cohorts. Effect of donor and recipient CMV serostatus on survival after.
Presentation transcript:

Use of ISBT 128 in the Labeling of Cellular Therapy Products Pat Distler Technical Director, ICCBBA

Copyright ICCBBA, Inc What is ISBT 128? International standard for the transfer of information associated with tissue, cellular therapy and blood products Provides  globally unique donation numbering system  Internationally standardized product definitions  Standard data structures for bar coding and electronic data interchange Independent of delivery mechanism (linear bar code, 2-D bar codes, RFID, electronic data interchange)

Copyright ICCBBA, Inc What is ICCBBA? Formerly International Council for Commonality in Blood Bank Automation Not-for-profit US-based organization Develops and manages ISBT 128 Standard Works with advisory groups of experts in the fields of tissues, cellular therapy and blood Interacts with other standard setting and regulatory organizations to ensure compatibility of the ISBT 128 Standard with existing standards and regulations

Copyright ICCBBA, Inc Status of ISBT 128 In use for almost 10 years for cell therapy, blood and tissue  Cellular Therapy: Some US and European Cellular Therapy facilities using ISBT 128. Used in cord blood banks all over the world  Blood: Blood banks in many countries are using ISBT 128 since 1997  Tissue: UK is using ISBT 128 for tissue banking; being evaluated for use with tissues in the US International standard setting organizations have committed to using ISBT 128 for cellular therapy products

Copyright ICCBBA, Inc Organizations Committed to ISBT 128 Standard for Cellular Therapy AABB American Society for Apheresis (ASFA) American Society for Blood and Marrow Transplant (ASBMT) European Group for Blood and Marrow Transplantation (EBMT) Foundation for Accreditation of Cellular Therapy (FACT) International Society for Blood Transfusion (ISBT) International Society for Cellular Therapy (ISCT) ISCT Europe Joint Accreditation Committee for ISCT and EBMT (JACIE) National Marrow Donor Program (NMDP) World Marrow Donor Association (WMDA)

Copyright ICCBBA, Inc Cellular Therapy Coding and Labeling Advisory Group Formed in 2005 to broaden the use of ISBT 128 in the area of cellular therapy Have defined terminology and label designs Will publish work this winter for public review An FDA liaison is invited to all meetings

Copyright ICCBBA, Inc ISBT 128 Process Steps Identify experts in the field Define terminology Encode information Create common databases Design standardized label

Copyright ICCBBA, Inc Common Terminology Select terminology through consensus Define selected terms Publish for broad input

Copyright ICCBBA, Inc Encode information (data structures) =<S0005A00 Data Structure Data Identifiers Data Content (product, donation type, divisions if any)

Copyright ICCBBA, Inc Common ICCBBA-maintained database Found on ICCBBA website  Accessible to users  Accessible to regulatory and standard setting organizations Reference tables for codes  For example, product code S0005 = Thawed HPC, Marrow|DMSO/XX/<-120C|Open|10% DMSO

Design standardized label Donor Information Blood Group If applicable Donor Information Test results etc. Recipient Information Expiration date & time If applicable Collection Information Collection Center or Registry ID Collection Date & Time Product Information Product Proper Name Volume & additives Storage conditions Processing Lab ID

Copyright ICCBBA, Inc

Cryo Vial Label

Copyright ICCBBA, Inc BioArchive TM Cord Blood Labels 1.75” 2” Courtesy of Thermogenesis

Copyright ICCBBA, Inc Importance of International Standardization Products commonly cross international borders (39% of NMDP products cross an international border)

Copyright ICCBBA, Inc What information can be encoded? Unique identifier including the manufacturer or registry name Product description Donation type ABO/Rh Biohazard if applicable Expiration date and time Collection date and time Special testing results (CMV or HLA) Donor identifier Patient identification number and date of birth

W Five character facility ID code Year Serial number Flags (number or icon) Check digit S 00

Copyright ICCBBA, Inc Facility Identification Number All facilities in the world are assigned a unique Facility ID code by ICCBBA May also encode a donor registry  Required by 42 U.S.C. 274K (f) (5) to ensure donor confidentiality  Registry maintains identity of collection facility Key (database) on ICCBBA website  Accessible to users and regulatory agencies Once assigned, the Donation Identification Number doesn’t change improving trackability  Exception: products from multiple donors are pooled into one container and a pool number is assigned

Copyright ICCBBA, Inc

Blood type, donation type and biohazard information encoded

Copyright ICCBBA, Inc ISBT 128 Product Codes Define the product in terms of its cellular content, anticoagulant, storage temperature and other attributes Do not include highly variable information (cell counts or amount of active/inactive ingredients) in bar coded information  This would create too many product codes to be manageable  Would require assigning of product codes on a very urgent basis  Would lose the benefit of standardization since receiving facility wouldn’t have the “key” to the code  Information is human readable on the label

Copyright ICCBBA, Inc Safety at Bedside Patient Identification Number Patient birth date Unit Label Patient Wristband

Copyright ICCBBA, Inc Advantages of ISBT 128 vs. NDC Designed for international use overcoming language barriers Provides collection, processing or registry ID Tracking number does not change during subsequent processing Provides specific product information but does not encode highly variable information Product codes are assigned in advance of need Delivers safety to patient bedside

Copyright ICCBBA, Inc Summary ISBT 128 is: Comprehensive system designed for cellular therapy products Proven system (in use for 10 years in CT labs, tissue banks and blood banks) Flexible enough to accommodate technological advances Structured enough to maintain global standardization